APA

Duan J., Cui L., Zhao X., Bai H., Cai S., Wang G., Zhao Z., Zhao J., Chen S., Song J., Qi C., Wang Q., Huang M., Zhang Y., Huang D., Bai Y., Sun F., Lee J. J., Wang Z. & Wang J. (20201218). Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis. : JAMA oncology.

Chicago

Duan Jianchun, Cui Longgang, Zhao Xiaochen, Bai Hua, Cai Shangli, Wang Guoqiang, Zhao Zhengyi, Zhao Jing, Chen Shiqing, Song Jia, Qi Chuang, Wang Qing, Huang Mengli, Zhang Yuzi, Huang Depei, Bai Yuezong, Sun Feng, Lee J Jack, Wang Zhijie and Wang Jie. 20201218. Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis. : JAMA oncology.

Harvard

Duan J., Cui L., Zhao X., Bai H., Cai S., Wang G., Zhao Z., Zhao J., Chen S., Song J., Qi C., Wang Q., Huang M., Zhang Y., Huang D., Bai Y., Sun F., Lee J. J., Wang Z. and Wang J. (20201218). Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis. : JAMA oncology.

MLA

Duan Jianchun, Cui Longgang, Zhao Xiaochen, Bai Hua, Cai Shangli, Wang Guoqiang, Zhao Zhengyi, Zhao Jing, Chen Shiqing, Song Jia, Qi Chuang, Wang Qing, Huang Mengli, Zhang Yuzi, Huang Depei, Bai Yuezong, Sun Feng, Lee J Jack, Wang Zhijie and Wang Jie. Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis. : JAMA oncology. 20201218.